Literature DB >> 20676786

Monocyte and macrophage abnormalities in systemic lupus erythematosus.

Yi Li1, Pui Y Lee, Westley H Reeves.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with profound effects on multiple organ systems. In patients with SLE, the immune system is subverted to target numerous self antigens and the ensuing inflammatory response elicits a vicious cycle of immune-cell activation and tissue damage. Both genetic and environmental factors are essential for the development of this debilitating condition, although the exact cause remains unclear. Early studies on the pathogenesis of lupus centered on the adaptive immune system as lymphocyte abnormalities were thought to be the primary cause of autoimmunity. In the past decade, however, this paradigm has shifted with rapid advances in the field of innate immunity. These developments have yielded important insights into how the autoimmune response in SLE is initiated and maintained. Monocytes and macrophages are an essential arm of the innate immune system with a multitude of immunological functions, including antigen presentation, phagocytosis, and cytokine production. Aberrations of monocyte/macrophage phenotype and function are increasingly recognized in SLE and animal models of the disease. In this review we summarize the current knowledge of monocyte/macrophage abnormalities in human SLE and discuss their implications for understanding the pathogenesis of lupus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676786      PMCID: PMC3785254          DOI: 10.1007/s00005-010-0093-y

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  117 in total

1.  Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice.

Authors:  Robert Berland; Luis Fernandez; Elina Kari; Jin-Hwan Han; Ina Lomakin; Shizuo Akira; Henry H Wortis; John F Kearney; Angelo A Ucci; Thereza Imanishi-Kari
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

2.  Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus.

Authors:  Dacheng Ding; Hemal Mehta; W Joseph McCune; Mariana J Kaplan
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

3.  The regulation of lymphocyte functions by the macrophage.

Authors:  E R Unanue
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

4.  FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis.

Authors:  Amy Bergtold; Anamika Gavhane; Vivette D'Agati; Michael Madaio; Raphael Clynes
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

5.  Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli.

Authors:  Karin S Peterson; Jing-Feng Huang; Jessica Zhu; Vivette D'Agati; Xuejun Liu; Nancy Miller; Mark G Erlander; Michael R Jackson; Robert J Winchester
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

6.  Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus.

Authors:  Chiang-Hua Liao; Tsung-Chieh Yao; Hung-Tao Chung; Lai-Chu See; Ming-Ling Kuo; Jing-Long Huang
Journal:  J Rheumatol       Date:  2004-10       Impact factor: 4.666

7.  IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis.

Authors:  M Nusrat Sharif; Ioannis Tassiulas; Yang Hu; Ingrid Mecklenbräuker; Alexander Tarakhovsky; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

8.  Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis.

Authors:  Hiroyuki Hanai; Fumitoshi Watanabe; Masami Yamada; Yoshihiko Sato; Ken Takeuchi; Takayuki Iida; Kotaro Tozawa; Tatsuo Tanaka; Yasuhiko Maruyama; Isao Matsushita; Yasushi Iwaoka; Abby Saniabadi
Journal:  Am J Gastroenterol       Date:  2004-08       Impact factor: 10.864

9.  Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE.

Authors:  Meggan Mackay; Anfisa Stanevsky; Tao Wang; Cynthia Aranow; Margaret Li; Scott Koenig; Jeffrey V Ravetch; Betty Diamond
Journal:  J Exp Med       Date:  2006-08-21       Impact factor: 14.307

Review 10.  Toll-like receptors in systemic autoimmune disease.

Authors:  Ann Marshak-Rothstein
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

View more
  58 in total

Review 1.  Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Authors:  M Wigren; J Nilsson; M J Kaplan
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

2.  Distinct roles of CSF-1 isoforms in lupus nephritis.

Authors:  Julia Menke; Yasunori Iwata; Whitney A Rabacal; Ranu Basu; E Richard Stanley; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

3.  Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus.

Authors:  Lisong Yang; Di Feng; Xiaohui Bi; Rivka C Stone; Betsy J Barnes
Journal:  J Immunol       Date:  2012-08-29       Impact factor: 5.422

4.  PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus.

Authors:  Begum Horuluoglu; Defne Bayik; Neslihan Kayraklioglu; Emilie Goguet; Mariana J Kaplan; Dennis M Klinman
Journal:  J Autoimmun       Date:  2019-01-22       Impact factor: 7.094

Review 5.  The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach.

Authors:  Frederick O Cope; Bonnie Abbruzzese; James Sanders; Wendy Metz; Kristyn Sturms; David Ralph; Michael Blue; Jane Zhang; Paige Bracci; Wiam Bshara; Spencer Behr; Toby Maurer; Kenneth Williams; Joshua Walker; Allison Beverly; Brooke Blay; Anirudh Damughatla; Mark Larsen; Courtney Mountain; Erin Neylon; Kaeli Parcel; Kapil Raghuraman; Kevin Ricks; Lucas Rose; Akhilesh Sivakumar; Nicholas Streck; Bryan Wang; Christopher Wasco; Larry S Schlesinger; Abul Azad; Murugesan V S Rajaram; Wael Jarjour; Nicholas Young; Thomas Rosol; Amifred Williams; Michael McGrath
Journal:  Nucl Med Biol       Date:  2015-12-03       Impact factor: 2.408

6.  Deletion of calponin 2 in macrophages attenuates the severity of inflammatory arthritis in mice.

Authors:  Qi-Quan Huang; M Moazzem Hossain; Wen Sun; Lianping Xing; Richard M Pope; J-P Jin
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

Review 7.  Metabolic Factors that Contribute to Lupus Pathogenesis.

Authors:  Wei Li; Ramya Sivakumar; Anton A Titov; Seung-Chul Choi; Laurence Morel
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

8.  Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients.

Authors:  Ziyan Wu; Shulan Zhang; Lidan Zhao; Yunyun Fei; Li Wang; Jing Li; Xiaoting Wen; Xiaofeng Zeng; Fengchun Zhang; Yongzhe Li
Journal:  Clin Rheumatol       Date:  2017-08-19       Impact factor: 2.980

Review 9.  Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases.

Authors:  Zejun Zhou; Miao Ding; Lei Huang; Gary Gilkeson; Ren Lang; Wei Jiang
Journal:  Clin Immunol       Date:  2016-09-09       Impact factor: 3.969

10.  A20 overexpression alleviates pristine-induced lupus nephritis by inhibiting the NF-κB and NLRP3 inflammasome activation in macrophages of mice.

Authors:  Min Li; Xiaowei Shi; Tian Qian; Jian Li; Zhiqiang Tian; Bing Ni; Fei Hao
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.